Patents Assigned to David W. Hill
  • Publication number: 20130303566
    Abstract: The present invention provides a method of treating a mammal with age-related macular degeneration (AMD) comprising administering a dosage of at least one of prostaglandin E1 (PGE1), papaverine, and an alpha-1-vasodilator, in a pharmaceutically acceptable carrier for a period of time effective to deliver a dosage effective to treat said AMD.
    Type: Application
    Filed: January 24, 2013
    Publication date: November 14, 2013
    Applicant: David W. Hill
    Inventor: David W. Hill